The United States represents a major market for dialyzers, supported by the high prevalence of chronic kidney disease and end-stage renal disease, along with a well-established dialysis care network. Increasing cases of diabetes and hypertension, coupled with growing demand for advanced renal replacement therapies, continue to drive the adoption of high-performance dialyzers across healthcare...